Clonidine impairs recovery of beam-walking after a sensorimotor cortex lesion in the rat.
Beam-walking in the rat is a useful model for studying the effects of drugs on motor recovery following brain injury. In the present experiment, the effect of clonidine HCl on beam-walking recovery was investigated. Groups of rats were first trained to traverse a narrow elevated beam and then subjected to a right sensorimotor cortex suction-ablation injury. After 24 h, each rat received a single dose of clonidine HCl (20, 60, or 200 micrograms/kg, i.p., salt weight) or saline. Recovery of beam-walking ability was scored over the next 12 days. Treatment with clonidine significantly slowed the rate of recovery (Kruskal-Wallis H = 8.755, df = 3; 0.02 less than P less than 0.05). Furthermore, the impairment persisted for at least 5 days after the rats were treated (Kruskal-Wallis H = 8.47, df = 3; 0.02 less than P less than 0.05). These data are consistent with the hypothesis that norepinephrine, working through central alpha 2-adrenergic receptors, influences motor recovery after a unilateral sensorimotor cortex lesion in the rat. Since many stroke patients are treated with centrally acting antihypertensive drugs, the potential effects of specific classes of these drugs during the recovery period, should be carefully considered.
Goldstein
L B
LB
Neurology Research Laboratory, Durham Department of Veterans' Affairs Medical Center, N.C. 27705.
Davis
J N
JN
D000818:Animals; D001930:Brain Injuries / Q000188:drug therapy / Q000503:physiopathology*; D002540:Cerebral Cortex; D002561:Cerebrovascular Disorders / Q000188:drug therapy / Q000503:physiopathology*; D003000:Clonidine / Q000627:therapeutic use*; D004195:Disease Models, Animal; D008297:Male; D009069:Movement Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D051381:Rats; D011919:Rats, Inbred Strains
D003000:Clonidine